Search results
Results from the WOW.Com Content Network
The real issue came from its forecast EPS for 2025. The high end of the range the company offered -- $2.65 -- comes in well below the expected $2.76. ... Before you buy stock in Teva ...
The stock of Teva Pharmaceutical Industries (NYSE:TEVA, 30-year Financials) is believed to be modestly undervalued, according to GuruFocus Value calculation.
Image source: The Motley Fool. Teva Pharmaceutical Industries (NYSE: TEVA) Q4 2024 Earnings Call Jan 29, 2025, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.62 in the latest trading session, marking a -1.03% move from the prior day.
Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs , but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing ...
Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $7.68, moving -0.13% from the previous trading session.
For premium support please call: 800-290-4726 more ways to reach us
In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $18.22, marking a -0.71% move from the previous day.